Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled, Randomized, Multi-centre, Double Blind, Phase II Study to Evaluate Efficacy and Safety of Topical PeproStat in Intraoperative Surgical Haemostasis

NCT03131336 is registered in ClinicalTrials.gov with Haemostatix Ltd as lead sponsor.

NCT NCT03131336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03131336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled, Randomized, Multi-centre, Double Blind, Phase II Study to Evaluate Efficacy and Safety of Topical PeproStat in Intraoperative Surgical Haemostasis
Lead sponsor
Haemostatix Ltd
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2017
Completion date
October 11, 2017
Enrollment
169 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding